Clinical Trials and Studies
Some clinical trials have suspended enrollment until further notice due to COVID-19 considerations.
Blood Disorders and Hematologic Cancers
- AB-101 with or without Rituximab for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- Assessing the Anti-Tumor Activity and Safety of REGN1979 in Patients with Relapsed or Refractory Follicular Lymphoma
- Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients (VICD)
- CGT9486 Treatment for Advanced Systemic Mastocytosis
- Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease Treatment Study
- Drug Treatment Study for Children with Hemophilia A
- Drug Treatment Study for High Grade B-Cell Lymphomas
- Evaluation of Pediatric Palliative Inpatient Process
- Health Literacy and Numeracy in Adolescent Patients with Hemophilia A and B Study
- Hemophilia A or B Treatment Study
- Hemophilia A Treatment Study
- Luspatercept versus Placebo in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis
- Mantle Cell Lymphoma Treatment Study
- Molecular and Clinical Biology of von Willebrand Disease Study
- National Registry of All Persons with Bleeding and Clotting Disorders
- Newly Diagnosed T-Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma Treatment Study
- Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
- Relapsed or Refractory Follicular Lymphoma Treatment Study
- Study for Patients with Acute Myelogenous Leukemia
- Study for Patients with Acute Myeloid Leukemia
- Study for Patients with Non-Advanced Systemic Mastocytosis
- Study of Biomarkers in Hemophilic Arthropathy
- Study of Hepatitis C Virus Outcomes After Treatment in Patients with Bleeding Disorders
- Study Treating Patients With High-Risk Smoldering Myeloma
- Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
- The National Myelodysplastic Syndromes Study
- Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma Study
- Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Study
- Treatment Study for Children with Hemophilia B
- Treatment Study for Newly Diagnosed High Risk B-Lymphoblastic Leukemia in Patients with Ph-like TKI Sensitive Mutations
- Treatment Study for Older Patients with Acute Lymphoblastic Leukemia
- Treatment Study for Patients with Localized Central Nervous System Germ Cell Tumors
- Treatment Study for Patients with Newly Diagnosed B-Lymphoblastic Leukemia or B-Lineage Lymphoblastic Lymphoma
- Treatment Study for Pediatric Patients with Hemophilia A
- Treatment Study for Subjects with Severe Hemophilia A or B
- Treatment Study for Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Breast Cancer
- Breast Cancer Collaborative Registry
- CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-Surgery Chemo and Targeted Therapy
- Estrogen Receptor Status Study
- Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- Study of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer (TAILOR RT)
- The CompassHER2 RD Trial for High Risk HER2-Positive Breast Cancer
- TMPS-101 Study for Metastatic Solid Tumor Patients
Gastrointestinal Cancers
- Act Fast Study for Patients with Colorectal Cancer or Colorectal Lesion
- Adenoma and Second Primary Prevention Trial
- Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas Treatment Study
- Advanced/Metastatic Colorectal Cancer with HER-2 Amplification Treatment Study
- Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
- Colonoscopy Research Study
- Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study
- Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
- EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients
- FORTE Study for Colorectal Cancer Prevention
- Growth of Colon Tissue to Evaluate GI
- High Risk Anal Cancer Treatment Study
- Initial Feasibility Study to Treat Pancreatic Cancer With a Planar LDR Source
- Pancreatic Cancer Screening Study
- Refractory Small Bowel Adenocarcinoma Treatment Study
- Retrospective Chart Review of Patients with Fibrolamellar Carcinoma
- Study for Patients with Hepatocellular Carcinoma (HCC)
- Study of Eating Patterns and Alcohol Consumption in Patients with Advanced Tubular Adenoma
- Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors
- The COMMIT Study: Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
- The DECREASE Study: Treatment of Early-Stage Anal Cancer
- Treatment Study for Patients With Stage III Colon Cancer
- Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Genitourinary Cancers
- Cabozantinib and Avelumab vs Maintenance Avelumab in Metastatic Urothelial Cancer
- Chemoradiotherapy Study for Patients with Localized Muscle Invasive Bladder Cancer
- Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
- Novel Treatment Combination Study for Metastatic Prostate Cancer Patients
- Prostate Cancer Study
- Prostate Cancer: De-Intensification and Intensification Clinical Trial
- Study of Combination Therapy for High Risk Prostate Cancer
- Study of Standard Systemic Therapy in Treating Prostate Cancer
- Study to Test Radium-223 with Docetaxel in Patients with Prostate Cancer
- The CASPAR Trial for Men with Metastatic Prostate Cancer that has become Resistant to Testosterone-Deprivation Therapy
- The ICONIC Trial for Rare Genitourinary Cancers
- The PREDICT-RT Trial for Patients with High Risk Prostate Cancer
- The PROBE Trial: Treatment Study for Metastatic Kidney Cancer
- The RadiCaL Study: Testing the Addition of a New Anti-Cancer Drug to the Usual Treatment for Advanced Renal Cell Cancer that has Spread to the Bone
- Treating Participants With Metastatic Prostate Cancer
- Treating Patients With High Risk Prostate Cancer
- Treating Patients With Metastatic, Castration-Resistant Prostate Cancer
- Treatment Study for Node-Positive Prostate Cancer After Radical Prostatectomy
- Treatment Study for Patients With Localized Muscle Invasive Bladder Cancer
- Treatment Study for Patients With Locally Advanced Bladder Cancer
- Treatment Study for Patients With Muscle-Invasive Bladder Cancer
- Treatment Study for Rare Genitourinary Cancers
Gynecologic Cancers
Head and Neck Cancer
- Advanced Pneumatic Compression Device
- Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer Treatment Study
- Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
- Lenvatinib in Combination with Pembrolizumab vs. Standard Chemotherapy in Head and Neck Cancer
- Locoregionally Advanced Head and Neck Cancer Treatment Study
- Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
- Testing Immunotherapy Versus Observation in Patients with HPV Throat Cancer
- The ASPEN-03 Study for Patients with Head and Neck Cancer
- The ASPEN-04 Study for Patients with Head and Neck Cancer
- Treatment Study for Squamous Cell Carcinoma of the Head and Neck
Melanoma and Soft Tissue
- Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients (Neo-DREAM)
- STAMP Study: Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer
- Treating Patients With Advanced Skin Squamous Cell Cancer
- Treatment Study for Patients With Desmoplastic Melanoma
- UV1-202 Vaccine Study in Combination with Nivolumab and Ipilimumab for Melanoma
Pediatric Cancers and Blood Disorders
- Childhood B-Lymphoblastic Leukemia Treatment Study
- Hepatoblastoma Treatment Study
- Newly Diagnosed Classical Hodgkin Lymphoma Treatment Study
- Retrospective Chart Review of Patients with Fibrolamellar Carcinoma
- Study of Transient Myeloproliferative Disorder in Children with Down Syndrome
- Treatment Study for Patients with Acute Myeloid Leukemia
- Treatment Study for Patients with Anaplastic Large Cell Lymphoma
- Treatment Study of Non-Metastatic Desmoplastic Medulloblastoma in Children